However, due to the number of death events in the F2-GOT2-TRPV1 high expression group of in the HCC biochips being 0, the survival analysis of the F2-GOT2-TRPV1 high and the expression group was marginally significant (p = 0.051), but this is still consistent with our above-mentioned big data-based multi-gene combination survival analysis results. This evidence concerns the gene TRPV1 and hepatocellular carcinoma.